Market Outlook for Americas Transplant Pathogen Monitoring
Newly released data from Fact.MR’s industry analysis on transplant pathogen monitoring in the Americas shows that the market enjoyed year-on-year (YoY) growth of 6.7% in 2021. Revenue from CMV PCR kits, EBV PCR kits, BKV PCR kits, aspergillus test kits, and multiplex PCR kits totaled US$ 298.8 Mn, according to the research conducted by Fact.MR, a market research and competitive intelligence provider.
Demand Analysis of Transplant Pathogen Monitoring from 2016 to 2020 Vs Market Outlook for 2021 to 2031
The transplant pathogen monitoring market is projected to expand at a CAGR of 6.7% from 2021 to 2031 in comparison to the above 6% CAGR registered during 2016 to 2020. This is driven by increasing geriatric population, rising incidence of chronic diseases, and an increasing burden of infectious diseases.
Increasing public-private funding for target research activities and technological advancements such as the application of STR-PCR and HLA typing in the field of transplant pathogen monitoring further accentuate market growth.
Furthermore, there is an increasing inclination towards preventive care testing and public awareness of organ transplants and organ donation. Increased risk in transplant patients due COVID-19 infection further introduced widespread need for transplant pathogen monitoring for the post-transplant period.
Technological advancements and their applications and innovative solutions to enhance healthcare facilities have positively affected the transplant pathogen monitoring scenario.
Blood sample crossmatch is the most widely adopted test for transplant pathogen monitoring. However, swab sample testing appears to present the most lucrative opportunities for market players, and is set to expand at a CAGR of 8.9%.
Demand growth of transplant pathogen monitoring is further augmented by increasing adoption of cross-matching and chimerism testing through the post-transplantation process.
What is the Impact of Increasing Number of Infections on Transplant Pathogen Monitoring?
The major risk of complications throughout the process of transplantation is the occurrence of infections. Infectious risks at an early stage are primarily related to postoperative and nosocomial infections. Opportunistic infections such as Cytomegalovirus occur after a significant time post-transplant, and are the most common cause of viral infections in transplant patients.
Adoption of transplant pathogen monitoring for an increased association of such infections is critical throughout the intermediate phase. The risk of community-acquired infections in transplant patients is highly common.
Prevalence of cytomegalovirus reflects that 50% of adults are infected with CMV by the age of 40, and over one in three children are infected by the age of 5 in the U.S., as per the Centers for Disease Control and WHO in 2019.
Early treatment of infections through transplantation diagnostic procedures is an efficient method for an advanced prognosis in patients with severe infections due to organ transplants.
Country-wise Insights
How Big is the U.S. Market for Transplant Pathogen Monitoring?
The U.S. transplant pathogen monitoring market dominates the region, and is expected to witness steady growth during the forecast period, according to Fact. MR.
The market analysis by Fact.MR shows the U.S. accounting for a market share of 67% in 2021. This leading stance is governed by the presence of an advanced healthcare system and the presence of major players in transplant pathogen monitoring.
High adoption of innovative transplant pathogen monitoring technologies among medical specialists and rising number of procedures involving organ transplantation in the country further augment market growth in the country.
Apart from these factors, there is high adoption of soft tissue transplants in the country, which are also augmenting market growth.
Why is Demand for Transplant Pathogen Monitoring Increasing in Canada?
The Canadian market is increasingly witnessing growing availability in transplant pathogen monitoring products, and is expected to witness a CAGR of 7.2% over the forecast period.
Growth is supported by increasing government initiatives and collaboration in transplant processes. Health Canada, by the government of Canada, leads an initiative called Organ Donation and Transplantation Collaborative, with the goal of improved patient outcomes and successful transplantation processes.
Rising availability of transplant pathogen monitoring products and services and prevalence of various government initiatives are set to promote market expansion in the country.
What is the Outlook for Transplant Pathogen Monitoring in Brazil?
The Brazil transplant pathogen monitoring market holds a current market share of 34.5%, and according to the analysis by Fact.MR, is expected to present high growth at a CAGR of 5.8% over the next ten years.
This growth is associated with the presence of favorable opportunities for organ procurement through donors. Brazil ranks first in the number of kidney transplantation procedures. Due to increasing number of organ transplantation patients, the wait time for these procedures is increasing.
Transplant pathogen monitoring is potentially linked to the practice of decreased waiting times through technological advancements. One such example is the application of machine learning approaches with evaluated predictors of comorbidities and infection-related data.
How is Mexico Faring in the Transplant Pathogen Monitoring Space?
In 2031, Mexico is set to account for over 30% of the market share as compared to a share of 28.7% at present. Growth in transplant pathogen monitoring is augmented by increasing number of organ transplant procedures within the country.
According to the National Transplant Center database, from the period of 2007-2019, over 34,931 transplants were performed in Mexico. The study indicated a rise in the number of transplant procedures from 18.9 per million population to 23.3 per million population annually.
High presence of transplant procedures and suggestive increase in their number have proven to be an augmentative factors for transplant pathogen monitoring throughout Mexico.
What is the Transplant Pathogen Monitoring Adoption Scenario in Argentina?
The Argentina transplant pathogen monitoring market is expected to expand the fastest at a CAGR of 8.6%. Increasing number of guidelines and recommendations over transplantation processes as well as diseases associated with it have led to high growth opportunity in Argentina.
A.A.E.E.H has developed a clinical practice guideline for surveillance, diagnosis, staging, and treatment of hepatocellular carcinoma, where the guidelines for surveillance of HCC are included. Such procedures have led to the initiation of rising transplant pathogen monitoring processes in Argentina.
Category-wise Insights
Why is Demand for Test Kits for Transplant Pathogen Monitoring Continuously Rising?
Test kits are used for rapid as well as accurate detection of infectious agents before a transplantation procedure. Based on product, BKV PCR kits is leading in terms of market share, estimated at 32.2% as of 2021.
The BK virus is highly prevalent in the general population, often as an asymptomatic polyomavirus. BKV is a major cause of infection in immunocompromised patients after a kidney transplant or hematopoietic stem cell transplant. This poses the problem of renal dysfunction.
Thus, the monitoring and diagnosis of BKV is extremely vital for the prevention of renal diseases and transplant failure. BKV PCR kits are real-time PCR assay kits intended for the detection as well as quantification of BKV DNA.
Why is Blood Serum Preferred as a Sample for Transplant Pathogen Monitoring?
Blood serum is the most widely adopted method of sampling for solid organ transplant pathogen monitoring. The segment is projected to expand at a CAGR of 5.5% over the forecast period.
Increasing adoption of serum crossmatch and rising technological advancements in transplant pathogen monitoring for transplant procedures concerning blood serum samples have led to an increased preference for blood serum as a sample for transplant pathogen monitoring.
The value of blood serum sample is expected to reach US$ 290 Mn by the end of the forecast period.
Why are Diagnostic Laboratories Flourishing Distribution Channels of Transplant Pathogen Monitoring?
Based on distribution channel, diagnostic laboratories depict a market share of 27.2% and are projected to increase at a CAGR of 7.6% over the next ten years.
Revenue from diagnostic laboratories is projected to account for over US$ 169.4 Mn by 2031. This growth is supported by advancements in serology and cellular assays. The need for improving the process for a successful transplant procedure has further led to the evolution of diagnostic laboratories.
How Has COVID-19 Affected the Transplant Pathogen Monitoring Industry?
The impact of the COVID-19 pandemic as an infectious disease resulted in a momentary halt on transplant procedures; however, diagnostic procedures were supported after a stagnant period during 2020.
The pandemic impacted donor and recipient suitability and mitigation of the presence of infection and its transmission. Various clinical specimens, including plasma and swab sample testing for the detection of infections concerning COVID-19 increased demand for transplant pathogen monitoring, along with donor and receiver screening for COVID-19-related infections during the pre-transplantation process as well as the post-transplantation process.
Moreover, rising awareness among the general population about the impact of COVID-19 infection and its prospective complications in transplant processes, as well as rise in technological advancements are set to propel demand for transplant pathogen monitoring over the coming years.
Competitive Landscape
Companies operating in the American transplant pathogen monitoring market are focused on innovative solutions to decrease the increasing burden of patient numbers for transplant procedures. This factor has encouraged key players to bring innovative solutions in transplant pathogen monitoring for infection monitoring as well as alternative methods for organ transplant surgeries.
Top American transplant pathogen monitoring companies also focus on geographical expansions to generate a larger footprint for sales of products and services.
- For instance, in 2020, Bio Rad Laboratories, Inc. launched the Exact Diagnostics Transplant product range in the European market for quality control of transplant procedures. The company set a firm footprint in the region with the launch of a product portfolio for transplant-associated infections.
Americas Transplant Pathogen Monitoring Market Report Scope
| Attribute |
Detail |
| Forecast Period |
2021 to 2031 |
| Historical Data Available for |
2016 to 2020 |
| Market Analysis |
USD Million for Value |
| Key Regions Covered |
North America; Latin America |
| Key Countries Covered |
US, Canada, Brazil, Mexico, Argentina |
| Key Market Segments Covered |
Test, Sample, Distribution Channel, Country |
| Key Companies Profiled |
Trinity Biotech Plc.; Bio Rad Laboratories, Inc.; Qiagen NV; Biomerieux SA; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; ELITechGroup |
| Report Coverage |
Market Forecasts, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing |
Available upon Request |
